{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:48:09Z","timestamp":1791978489251,"version":"4.4.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec><jats:title>Purpose of review<\/jats:title><jats:p>Glycogen storage disease Ib (GSD Ib) is characterized by hepatomegaly, hypoglycemia, neutropenia, enterocolitis and recurrent bacterial infections. It is attributable to mutations in<jats:italic toggle=\"yes\">G6PT1<\/jats:italic>, the gene for the glucose-6-phosphate transporter responsible for transport of glucose into the endoplasmic reticulum. Neutropenia in GSD Ib is now frequently treated with granulocyte colony-stimulating factor (G-CSF). We formed a cooperative group to review outcomes of the long-term treatment of GSD Ib patients treated with G-CSF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Recent findings<\/jats:title><jats:p>The study enrolled 103 patients (48 men and 55 women), including 47 currently adult patients. All of these patients were treated with G-CSF, starting at a median age of 3.8 years (range 0.04\u201333.9 years) with a median dose of 3.0\u200amcg\/kg\/day (range 0.01\u201393.1\u200amcg\/kg\/day) for a median of 10.3 years (range 0.01\u201329.3 years). Neutrophils increased in response to G-CSF in all patients (median values before G-CSF 0.2 \u00d7 10<jats:sup>9<\/jats:sup>\/l, on G-CSF 1.20 x 10<jats:sup>9<\/jats:sup>\/l). Treatment increased spleen size (before G-CSF, 47%, on treatment on G-CSF 76%), and splenomegaly was the dose-limiting adverse effect of treatment (pain and early satiety). Clinical observations and records attest to reduce frequency of infectious events and the severity of inflammatory bowel symptoms, but fever and recurrent infections remain a significant problem. In the cohort of patients followed carefully through the Severe Chronic Neutropenia International Registry, four patients have developed myelodysplasia or acute myeloid leukemia and we are aware of four other cases, (altogether seven on G-CSF, one never treated with G-CSF). Liver transplantation in five patients did not correct neutropenia. Four patients had hematopoietic stem cell transplantation; two adults and two children were transplanted; one adult and one child survived.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>GSD Ib is a complex disorder of glucose metabolism causing severe chronic neutropenia. G-CSF is effective to raise blood neutrophil counts and reduce fevers and infections in most patients. In conjunction with other therapies (salicylates, mesalamine sulfasalazine and prednisone), G-CSF ameliorates inflammatory bowel symptoms, but doses must be limited because it increases spleen size associated with abdominal pain.<\/jats:p><\/jats:sec>","DOI":"10.1097\/moh.0000000000000474","type":"journal-article","created":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T16:28:24Z","timestamp":1542472104000},"page":"16-21","source":"Crossref","is-referenced-by-count":64,"title":["Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor"],"prefix":"10.1097","volume":"26","author":[{"given":"David C.","family":"Dale","sequence":"first","affiliation":[{"name":"Division of GIM, Department of Medicine, University of Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey Anna","family":"Bolyard","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington, Severe Chronic Neutropenia International Registry, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Marrero","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington, Severe Chronic Neutropenia International Registry, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merideth L.","family":"Kelley","sequence":"additional","affiliation":[{"name":"Division of GIM, Department of Medicine, University of Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahagn","family":"Makaryan","sequence":"additional","affiliation":[{"name":"Division of GIM, Department of Medicine, University of Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington, Severe Chronic Neutropenia International Registry, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington, Severe Chronic Neutropenia International Registry, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence A.","family":"Boxer","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Oncology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Austin","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corbinian","family":"Wanner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Glycogen Storage Disease Program, Connecticut Children's Medical Center, Hartford, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris A.","family":"Ferrecchia","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Glycogen Storage Disease Program, Connecticut Children's Medical Center, Hartford, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Khalaf","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Maze","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Kurtzberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics\/Pediatric Blood and Marrow Transplantation\/Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Zeidler","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopoiesis, Medizinische Hochschule Hannover, Hannover"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Welte","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Molecular Hematopoiesis, University Children's Hospital of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Weinstein","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Glycogen Storage Disease Program, Connecticut Children's Medical Center, Hartford, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230917","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet Med"},{"key":"R2-20230917","doi-asserted-by":"crossref","DOI":"10.1007\/s10545-018-0180-5","article-title":"Molecular biology and gene therapy for glycogen storage disease type Ib","author":"Chou","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"R3-20230917","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00431-005-1657-4","article-title":"Genotype\/phenotype correlation in glycogen storage disease type 1b: a multicentre study and review of the literature","volume":"164","author":"Melis","year":"2005","journal-title":"Eur J Pediatr"},{"key":"R4-20230917","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/mgme.2001.3179","article-title":"Molecular genetics of type 1 glycogen storage disease","volume":"73","author":"Janecke","year":"2001","journal-title":"Mol Genet Metab"},{"key":"R5-20230917","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1182\/blood-2013-05-502435","article-title":"Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib","volume":"123","author":"Jun","year":"2014","journal-title":"Blood"},{"key":"R6-20230917","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1172\/JCI115049","article-title":"Chronic neutropenia: a new canine model induced by human G-CSF","volume":"87","author":"Hammond","year":"1991","journal-title":"J Clin Invest"},{"key":"R7-20230917","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood.V88.1.335.335","article-title":"The effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans","volume":"88","author":"Price","year":"1996","journal-title":"Blood"},{"key":"R8-20230917","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1182\/blood.V88.12.4435.bloodjournal88124435","article-title":"Multiple signaling pathways induced by granulocyte colony-stimulating factor involvingactivation of JAKs, STAT5, and\/or STAT3 are required for regulation of three distinct classes of immediate early genes","volume":"88","author":"Tian","year":"1996","journal-title":"Blood"},{"key":"R9-20230917","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.4049\/jimmunol.1502690","article-title":"Changes in gene expression during G-CSF-induced emergency granulopoiesis in humans","volume":"197","author":"Pedersen","year":"2016","journal-title":"J Immunol"},{"key":"R10-20230917","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJM199206183262504","article-title":"Brief report: treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors","volume":"326","author":"Roe","year":"1992","journal-title":"N Engl J Med"},{"issue":"(Suppl 1)","key":"R11-20230917","first-page":"S120","article-title":"Consensus guidelines for management of glycogen storage disease type 1b: European Study on Glycogen Storage Disease Type 1","volume":"161","author":"Visser","year":"2002","journal-title":"Eur J Pediatr"},{"issue":"(Suppl 1)","key":"R12-20230917","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1007\/BF02680002","article-title":"Association of glycogen storage disease 1b and Crohn disease: results of a North American survey","volume":"161","author":"Dieckgraefe","year":"2002","journal-title":"Eur J Pediatr"},{"issue":"(Suppl 1)","key":"R13-20230917","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1007\/BF02679989","article-title":"Glycogen storage disease type I: diagnosis and phenotype\/genotype correlation","volume":"161","author":"Matern","year":"2002","journal-title":"Eur J Pediatr"},{"key":"R14-20230917","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood.V97.2.376","article-title":"Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and\/or neutrophil dysfunction secondary to glycogen storage disease type 1b","volume":"97","author":"Calderwood","year":"2001","journal-title":"Blood"},{"key":"R15-20230917","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7326\/0003-4819-120-3-199402010-00008","article-title":"Glycogen storage disease in adults","volume":"120","author":"Talente","year":"1994","journal-title":"Ann Intern Med"},{"issue":"(Suppl 1)","key":"R16-20230917","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1007\/s00431-002-1010-0","article-title":"Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1","volume":"161","author":"Visser","year":"2002","journal-title":"Eur J Pediatr"},{"key":"R17-20230917","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00054725-200105000-00008","article-title":"Hara T. inflammatory bowel disease-like colitis in glycogen storage disease type 1b","volume":"7","author":"Yamaguchi","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"R18-20230917","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0022-3476(84)80020-7","article-title":"Acute myelogenous leukemia and malignant hyperthermia in a patient with type 1b glycogen storage disease","volume":"105","author":"Simmons","year":"1984","journal-title":"J Pediatr"},{"key":"R19-20230917","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00043426-200212000-00015","article-title":"Acute myelogenous leukemia and glycogen storage disease 1b","volume":"24","author":"Pinsk","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"R20-20230917","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/1752-1947-2-319","article-title":"A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t (3;8)(q26;q24) after 14 years of treatment with granulocyte colony-stimulating factor (G-CSF): a case report","volume":"2","author":"Schroeder","year":"2008","journal-title":"J Med Case Rep"},{"key":"R21-20230917","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/08880018.2018.1440675","article-title":"Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length","volume":"35","author":"Li","year":"2018","journal-title":"Pediatr Hematol Oncol"},{"key":"R22-20230917","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bbrc.2016.11.075","article-title":"Glycogen storage disease type Ib neutrophils exhibit impaired cell adhesion and migration","volume":"482","author":"Kim","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"R23-20230917","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1750-1172-8-84","article-title":"A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutations","volume":"8","author":"Banka","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"R24-20230917","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/AOG.0000000000000602","article-title":"Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia","volume":"125","author":"Boxer","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R25-20230917","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3324\/haematol.2013.099101","article-title":"Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry","volume":"99","author":"Zeidler","year":"2014","journal-title":"Haematologica"},{"key":"R26-20230917","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2010.08216.x","article-title":"Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy","volume":"150","author":"Rosenberg","year":"2010","journal-title":"Br J Haematol"},{"key":"R27-20230917","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MOH.0000000000000105","article-title":"The diversity of mutations and clinical outcomes for ELANE associated neutropenia","volume":"22","author":"Makaryan","year":"2015","journal-title":"Curr Op Hematol"},{"key":"R28-20230917","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMc1709258","article-title":"Long-term effects of G-CSF therapy in cyclic neutropenia","volume":"377","author":"Dale","year":"2017","journal-title":"N Engl J Med"},{"key":"R29-20230917","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MOH.0000000000000305","article-title":"An update on the diagnosis and treatment of chronic idiopathic neutropenia","volume":"24","author":"Dale","year":"2017","journal-title":"Curr Opin Hematol"},{"key":"R30-20230917","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood-2017-08-801985","article-title":"Somatic mutations and clonal hematopoiesis in congenital neutropenia","volume":"131","author":"Xia","year":"2018","journal-title":"Blood"}],"container-title":["Current Opinion in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00062752-201901000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T13:46:53Z","timestamp":1720792013000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00062752-201901000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/moh.0000000000000474","relation":{},"ISSN":["1065-6251","1531-7048"],"issn-type":[{"value":"1065-6251","type":"print"},{"value":"1531-7048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}